Home

lugtfri diskret farve nature parkinson s disease værdighed Alvorlig Sygdom

Mice with disrupted mitochondria used to model Parkinson's disease
Mice with disrupted mitochondria used to model Parkinson's disease

Lysosomes to combat Parkinson's disease | Nature Neuroscience
Lysosomes to combat Parkinson's disease | Nature Neuroscience

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease |  Nature Communications
Metabolomics of sebum reveals lipid dysregulation in Parkinson's disease | Nature Communications

Defects in trafficking bridge Parkinson's disease pathology and genetics |  Nature
Defects in trafficking bridge Parkinson's disease pathology and genetics | Nature

Advances in the genetics of Parkinson disease | Nature Reviews Neurology
Advances in the genetics of Parkinson disease | Nature Reviews Neurology

The two-century journey of Parkinson disease research | Nature Reviews  Neuroscience
The two-century journey of Parkinson disease research | Nature Reviews Neuroscience

Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein |  Nature Reviews Neuroscience
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The  Evolution of Critical Symptoms
Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Parkinson's Disease: Early Symptoms and When to See a Neurologist |  Neurology Associates
Parkinson's Disease: Early Symptoms and When to See a Neurologist | Neurology Associates

Genetics of Parkinson disease: paradigm shifts and future prospects | Nature  Reviews Genetics
Genetics of Parkinson disease: paradigm shifts and future prospects | Nature Reviews Genetics

Parkinson disease and the immune system — associations, mechanisms and  therapeutics | Nature Reviews Neurology
Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology

Cognitive decline in Parkinson disease | Nature Reviews Neurology
Cognitive decline in Parkinson disease | Nature Reviews Neurology

Inflammation and immune dysfunction in Parkinson disease | Nature Reviews  Immunology
Inflammation and immune dysfunction in Parkinson disease | Nature Reviews Immunology

iPSC modeling of young-onset Parkinson's disease reveals a molecular  signature of disease and novel therapeutic candidates | Nature Medicine
iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates | Nature Medicine

Expanding insights of mitochondrial dysfunction in Parkinson's disease |  Nature Reviews Neuroscience
Expanding insights of mitochondrial dysfunction in Parkinson's disease | Nature Reviews Neuroscience

Parkinson's disease grafts benefit from well-timed growth factor
Parkinson's disease grafts benefit from well-timed growth factor

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Non-motor features of Parkinson disease | Nature Reviews Neuroscience
Non-motor features of Parkinson disease | Nature Reviews Neuroscience

Parkinson disease | Nature Reviews Disease Primers
Parkinson disease | Nature Reviews Disease Primers

Parkinson's disease - The Lancet
Parkinson's disease - The Lancet